Johnson Investment Counsel’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,337
Closed -$216K 652
2021
Q2
$216K Buy
+1,337
New +$216K ﹤0.01% 599